These terms may be updated from time to time and will be valid from the date of publication.
Unless otherwise stated, TROG Cancer Research owns or is licensed to use, the intellectual property, including copyright, of all content on this website.
You may view and print pages from the websites for your own use, subject to the restrictions below.
You are not permitted to:
You may seek approval for use of information outside of these terms by contacting us.
While every effort has been made to ensure the information contained in each area of this website is up-to-date and accurate, TROG Cancer Research makes no warranty about its accuracy or completeness.
To the extent permitted by law, TROG Cancer Research, its partners, directors, employees, and agents exclude all liability (whether in negligence or otherwise) for:
TROG Cancer Research is committed to safeguarding the privacy of our website visitors. This statement sets out how we will use your personal information.
We may collect the following information:
TROG Cancer Research’s website uses Google Analytics and HubSpot to analyse the use of this website.
The information generated is used to create reports about the use of the site.
Your data will be used as specified in these terms and conditions or in relevant parts of the website.
We may use your information to:
We will not, without your express consent, provide your information to any third parties for direct marketing.
We may disclose information about you:
We will take reasonable technical and organisational precautions to prevent the loss, misuse, or alteration of your personal information.
It should be noted that data transmission over the internet is inherently insecure, and we cannot guarantee the security of data sent over the internet.
You are responsible for keeping your password and user details confidential in the staff portal.
Use of the TROG Cancer Research website is governed by the laws of New South Wales, Australia.
If you have any questions about these terms and conditions, please contact us.
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292